These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 9836644)

  • 21. Frequency of CCR5-Δ32, CCR2-64I and SDF1-3'A alleles in HIV-infected and uninfected patients in Istanbul, Turkey.
    Köksal MO; Akgül B; Beka H; Çiftçi S; Keskin F; Eraksoy H; Ağaçfidan A
    J Infect Dev Ctries; 2021 Aug; 15(8):1183-1189. PubMed ID: 34516427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
    Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
    AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3'A in pediatric HIV-1 infection.
    Mangano A; Kopka J; Batalla M; Bologna R; Sen L
    J Acquir Immune Defic Syndr; 2000 Jan; 23(1):52-7. PubMed ID: 10708056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Distribution of the HIV-1 resistance-conferring alleles (CCR5delta32, CCR2-64I, and SDF1 3'A) in Russian, Ukrainian, and Belarusian populations].
    Kozhekbaeva GM; Borodina TA; Borinskaia SA; Gusar VA; Feshchenko SP; Akhmetova VL; Khusainova RI; Gupalo EIu; Spitsyn VA; Grechanina EIa; Khusnutdinova éK; Iankovskiĭ NK
    Genetika; 2004 Oct; 40(10):1394-401. PubMed ID: 15575507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression.
    Kristiansen TB; Knudsen TB; Ohlendorff S; Eugen-Olsen J
    J Immunol Methods; 2001 Jun; 252(1-2):147-51. PubMed ID: 11334974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatial genetic structure of two HIV-I-resistant polymorphisms (CCR2-64 I and SDF1-3'A) alleles in population of Shandong Province, China.
    Xue FZ; Wang JZ; Ma DX; Li GR; Hu P
    Biomed Environ Sci; 2005 Aug; 18(4):241-53. PubMed ID: 16274106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Summaries for patients. Genes and HIV progression.
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759637
    [No Abstract]   [Full Text] [Related]  

  • 28. Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.
    Sei S; Boler AM; Nguyen GT; Stewart SK; Yang QE; Edgerly M; Wood LV; Brouwers P; Venzon DJ
    AIDS; 2001 Jul; 15(11):1343-52. PubMed ID: 11504955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
    Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
    Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
    Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
    Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of CCR2-64I, SDF1-3'A and CCR5-Delta32 alleles in healthy Thais.
    Nookhai S; Ruxrungtham K; Phanuphak P; Oelrichs R
    Eur J Immunogenet; 2000 Jun; 27(3):153-7. PubMed ID: 10940085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.
    Su B; Sun G; Lu D; Xiao J; Hu F; Chakraborty R; Deka R; Jin L
    Eur J Hum Genet; 2000 Dec; 8(12):975-9. PubMed ID: 11175286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression.
    Winkler CA; Hendel H; Carrington M; Smith MW; Nelson GW; O'brien SJ; Phair J; Vlahov D; Jacobson LP; Rappaport J; Vasilescu A; Bertin-Maghit S; An P; Lu W; Andrieu JM; Schächter F; Therwath A; Zagury JF
    J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1534-8. PubMed ID: 15602133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
    Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
    J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Better CD4+ T cell recovery in Brazilian HIV-infected individuals under HAART due to cumulative carriage of SDF-1-3'A, CCR2-V64I, CCR5-D32 and CCR5-promoter 59029A/G polymorphisms.
    Rigato PO; Hong MA; Casseb J; Ueda M; de Castro I; Benard G; Duarte AJ
    Curr HIV Res; 2008 Sep; 6(5):466-73. PubMed ID: 18855658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.
    Kostrikis LG; Neumann AU; Thomson B; Korber BT; McHardy P; Karanicolas R; Deutsch L; Huang Y; Lew JF; McIntosh K; Pollack H; Borkowsky W; Spiegel HM; Palumbo P; Oleske J; Bardeguez A; Luzuriaga K; Sullivan J; Wolinsky SM; Koup RA; Ho DD; Moore JP
    J Virol; 1999 Dec; 73(12):10264-71. PubMed ID: 10559343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
    Kostrikis LG; Huang Y; Moore JP; Wolinsky SM; Zhang L; Guo Y; Deutsch L; Phair J; Neumann AU; Ho DD
    Nat Med; 1998 Mar; 4(3):350-3. PubMed ID: 9500612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
    Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
    AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans.
    An P; Martin MP; Nelson GW; Carrington M; Smith MW; Gong K; Vlahov D; O'Brien SJ; Winkler CA
    AIDS; 2000 Sep; 14(14):2117-22. PubMed ID: 11061652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.